Keyword Suggestions

Results
 
 
Account Login
 
 
 
 
 

Library Navigation

 
 

Browse Meetings

 
 
 
Biodegradable Polymersomes Engineered with Bcl-xL siRNA- and Doxorubicin-loaded Core-shell for Combined Cancer Therapy 
Date/Time:
April 22, 2013   9:00am - 10:00am
 
Speaker:
 
Format:
 
  Video Only
 
Share:
 

Combined therapy via simultaneous administration of multiple medications is a universal and highly effective strategy to treat cancer due to the unique metabolic divergences of this disease. Generally, combined treatment with drug and genetic components exhibits superior therapeutic efficacy compared with administration of the individual treatments, respectively. This is mainly because i) cytotoxic chemotherapeutic agents primarily affect the dividing cells and cause cell death through apoptosis, and ii) genes further induce additive cell killing effect and/or increase the sensitivity of cancer cells to chemotherapeutic agents, thus synergistically increasing therapeutic efficacy. For the simultaneous delivery of drug and gene while maintaining their chemophysical properties and biological functions, sophisticated nanocarriers have been designed.
 


 
 
Average Rating: (No Ratings)
  Was great, surpassed expectations, and I would recommend this
  Was good, met expectations, and I would recommend this
  Was okay, met most expectations
  Was okay but did not meet expectations
  Was bad and I would not recommend this
 



Submit
 
Matrix Independent Label-Free Nanoelectronic Biosensor, Nanoneedle Array
Grain Size Enginerring for Ferroelectric (Hf,Zr)O2 Films by insertion of Thin Al2O3 Layer
Nanoanalytical investigations at the interface of 4H-SiC/SiO2 MOSFETs
Exfoliated Metallic MX2 Nanosheets for Electrocatalytic and Photoelectrochemical Applications
Scaffold-free Three-dimensional Cell Assembly for Bottom-up Tissue Engineering